A new study by University of Pittsburgh researchers has found that women who exclusively breastfeed their children for at least one month are less likely to develop type 2 diabetes. The researchers studied the records of 2233 women, including 1828 mothers of which 56% breastfed their children for at least one month. The researchers...

The continuing controversy surrounding the cardiovascular risk of GlaxoSmithKline’s diabetes drug Avandia has led to sharp declines in its use and a surge in sales of the competing drug, Actos. Although the drugs are similar and both had FDA warnings in 2007, Takeda’s Actos has been perceived to be safer for the treatment...

Raise up your asparagus spear and fight!  Diabetes UK is funding research into foods such as garlic, chicory, asparagus and artichokes, according to a report in Telegraph.  These foods, known as fermentable carbohydrates, are thought to activate the release of gut hormones that reduce appetite.  It is believed such fermentable...

Eating green leafy vegetables may reduce risk of type 2 diabetes, a new study shows. According to the study published in the British Medical Journal, increasing daily consumption of green leafy vegetables could significantly reduce the risk of type 2 diabetes. The researchers investigated the independent effects of intake of fruit and...

According to a new study published online in Diabetologia, obese adolescents with type 2 diabetes may experience changes in their brains that affect how well they are learning in school. Cognitive and brain impairments, have been documented in adults with type 2 diabetes who also have multiple co-morbid disorders...

A new study has found that popular diabetes drugs Actos and Avandia boost the risk of fracture in older women. The researchers, lead by William H. Herman, MD, MPH, professor of medicine and epidemiology at the University of Michigan, Ann Arbor, evaluated a large database of managed care patients who had diabetes. He found that those...

Researchers led by Columbia University Medical Center have discovered that the skeleton plays an important role in regulating blood sugar and have further illuminated how bone controls this process. The finding, published in Cell, is important because it may lead to more targeted drugs for type 2 diabetes. Led by Gerard Karsenty,...

GlaxoSmithKline confirmed today that it will suspend enrollment of new patients in the Thiazolidinedione Intervention with Vitamin D Evaluation (TIDE) clinical trial at the request of the U.S. Food and Drug Administration (FDA) pending FDA  review of recommendations from its  Advisory Committee meeting July 13-14. Patients already...

A new study by researchers at the German Institute for Nutritional Research in Potsdam-Rehbrücke has found that waist circumference gives a better prediction of diabetes risk than does BMI, EurekAlert reports. Current guidelines recommend that the degree of risk of diabetes from excess weight should be based on the determination of the...

GlaxoSmithKline confirmed that a joint advisory committee to the U.S. Food and Drug Administration (FDA) voted to allow the diabetes drug Avandia to remain on the market. Committee members voted for recommendations ranging from making no changes to the current label, to revising the label with additional warnings and restrictions (20)...